Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 160 Total
MPW - Medical Properties Trust Inc - Stock Price Chart
TickerMPW [NYSE]
CompanyMedical Properties Trust Inc
CountryUSA
IndustryREIT - Healthcare Facilities
Market Cap2.70BEPS (ttm)-0.93
P/E-EPS this Y146.39%
Forward P/E8.53EPS next Y22.24%
PEG-EPS past 5Y-
P/S3.09EPS next 5Y-
P/B0.35EPS Q/Q-370.31%
Dividend12.92%Sales Q/Q-132.16%
Insider Own1.94%Inst Own71.85%
Insider Trans0.00%Inst Trans0.47%
Short Float37.34%EarningsMay 09/b
Analyst Recom3.17Target Price4.95
Avg Volume18.42M52W Range2.92 - 10.74
Medical Properties Trust, Inc. is a self-advised real estate investment trust. It engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie in 2003 and is headquartered in Birmingham, AL.
CETY - Clean Energy Technologies Inc - Stock Price Chart
TickerCETY [NASD]
CompanyClean Energy Technologies Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap57.18MEPS (ttm)-0.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.24%
P/S3.78EPS next 5Y-
P/B10.27EPS Q/Q-298.50%
Dividend-Sales Q/Q3468.80%
Insider Own70.84%Inst Own0.43%
Insider Trans0.00%Inst Trans-
Short Float1.06%EarningsNov 28/b
Analyst Recom-Target Price-
Avg Volume804.27K52W Range0.45 - 3.12
Clean Energy Technologies, Inc. engages in the provision of renewable and energy efficient products and solutions. It operates through the following segments: Clean Energy HRS, CETY Europe, Engineering and Manufacturing Business, and CETY HK. The Clean Energy HRS segment includes waste heat recovery, waste to energy, China liquefied natural gas initiatives, and engineering and consulting services. The CETY Europe segment offers services to European countries. The Manufacturing and Engineering segment consists of the electronics manufacturing business. The company was founded by Kambiz Mahdi and Reza Zarif in 1993 and is headquartered in Irvine, CA.
NYXH - Nyxoah SA - Stock Price Chart
TickerNYXH [NASD]
CompanyNyxoah SA
CountryBelgium
IndustryMedical Instruments & Supplies
Market Cap258.80MEPS (ttm)-1.68
P/E-EPS this Y-11.54%
Forward P/E-EPS next Y-2.77%
PEG-EPS past 5Y-27.28%
P/S55.06EPS next 5Y-
P/B2.39EPS Q/Q22.15%
Dividend-Sales Q/Q47.13%
Insider Own67.69%Inst Own12.83%
Insider Trans0.00%Inst Trans-
Short Float2.90%EarningsMar 05/a
Analyst Recom1.50Target Price20.06
Avg Volume45.97K52W Range4.00 - 20.00
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
FNGR - FingerMotion Inc - Stock Price Chart
TickerFNGR [NASD]
CompanyFingerMotion Inc
CountrySingapore
IndustryTelecom Services
Market Cap182.35MEPS (ttm)-0.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.69%
P/S4.51EPS next 5Y-
P/B14.43EPS Q/Q35.88%
Dividend-Sales Q/Q-46.15%
Insider Own29.44%Inst Own3.88%
Insider Trans0.00%Inst Trans-6.52%
Short Float5.80%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume313.00K52W Range1.28 - 7.97
Fingermotion Inc. is a mobile data specialist company, which engages in the provision of payment and recharge service, data plans, subscription plans, mobile phones, loyalty points redemption, and other product bundles. It operates through the following segments: Telecommunications and Product Services, Value Added Products and Services, Short Message Services and Multimedia Messaging Services, Rich Communication Services Platform, and Big Data Insights. The company was founded on January 23, 2014, and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shen Martin Chung-WenCEOSep 14 '23Option Exercise3.8492,000353,280797,000Sep 14 06:42 PM
Lee Yew HonCFOSep 14 '23Option Exercise3.8488,400339,456538,400Sep 14 06:28 PM
Leong Yew PohDirectorSep 05 '23Sale5.7012,50071,250200,000Sep 05 07:28 PM
Leong Yew PohDirectorAug 30 '23Sale5.502,17611,968212,500Aug 31 12:39 PM
Leong Yew PohDirectorJul 31 '23Sale5.797,82445,319214,676Jul 31 07:27 PM
SNPX - Synaptogenix Inc - Stock Price Chart
TickerSNPX [NASD]
CompanySynaptogenix Inc
CountryUSA
IndustryBiotechnology
Market Cap5.13MEPS (ttm)-43.39
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y8.59%
P/S-EPS next 5Y-
P/B0.19EPS Q/Q-108.10%
Dividend-Sales Q/Q-
Insider Own3.24%Inst Own5.03%
Insider Trans0.00%Inst Trans-
Short Float3.21%Earnings-
Analyst Recom3.00Target Price350.00
Avg Volume49.98K52W Range3.53 - 47.00
Apr-24-24 09:15AM Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing (PR Newswire)
Apr-09-24 09:15AM Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics (PR Newswire) -8.35%
Apr-03-24 08:00AM Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing (PR Newswire)
Dec-19-23 09:00AM Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders (PR Newswire) +5.45%
Dec-06-23 09:00AM Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's (PR Newswire)
Nov-02-23 09:00AM Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology (PR Newswire)
Sep-26-23 09:00AM Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease (PR Newswire) +5.67%
Sep-07-23 09:00AM Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study (PR Newswire) -12.23%
Jul-19-23 09:00AM Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis (PR Newswire)
Jul-13-23 09:00AM Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience (PR Newswire) +20.79%
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer's disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson's Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.
HOLO - MicroCloud Hologram Inc - Stock Price Chart
TickerHOLO [NASD]
CompanyMicroCloud Hologram Inc
CountryChina
IndustryElectronic Components
Market Cap12.59MEPS (ttm)-1.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-483.40%
P/S0.44EPS next 5Y-
P/B0.63EPS Q/Q-320.24%
Dividend-Sales Q/Q-
Insider Own69.53%Inst Own1.00%
Insider Trans0.00%Inst Trans-98.39%
Short Float42.90%Earnings-
Analyst Recom-Target Price-
Avg Volume10.80M52W Range1.50 - 113.00
MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.
DNTH - Dianthus Therapeutics Inc - Stock Price Chart
TickerDNTH [NASD]
CompanyDianthus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap702.05MEPS (ttm)-13.05
P/E-EPS this Y77.08%
Forward P/E-EPS next Y-18.85%
PEG-EPS past 5Y29.95%
P/S508.73EPS next 5Y-
P/B2.10EPS Q/Q86.61%
Dividend-Sales Q/Q-
Insider Own26.58%Inst Own42.66%
Insider Trans0.00%Inst Trans5.07%
Short Float8.86%EarningsMar 21/a
Analyst Recom1.17Target Price50.17
Avg Volume171.90K52W Range6.58 - 33.77
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fairmount Funds Management LLCDirectorSep 29 '23Buy13.6324,670336,2521,928,503Oct 03 04:00 PM
Fairmount Funds Management LLCDirectorSep 26 '23Buy13.1530,000394,5001,903,833Sep 28 05:09 PM
Randhawa SimratChief Medical OfficerSep 22 '23Buy13.202,00026,4004,000Sep 25 04:15 PM
Randhawa SimratChief Medical OfficerSep 21 '23Buy13.202,00026,4002,000Sep 25 04:15 PM
Fairmount Funds Management LLCDirectorSep 19 '23Buy13.2030,000396,0001,873,833Sep 21 04:23 PM
XBIO - Xenetic Biosciences Inc - Stock Price Chart
TickerXBIO [NASD]
CompanyXenetic Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap6.10MEPS (ttm)-2.71
P/E-EPS this Y-397.10%
Forward P/E-EPS next Y76.09%
PEG-EPS past 5Y51.08%
P/S2.40EPS next 5Y-
P/B0.62EPS Q/Q22.03%
Dividend-Sales Q/Q37.99%
Insider Own18.58%Inst Own1.10%
Insider Trans0.00%Inst Trans-27.44%
Short Float0.22%EarningsNov 10/b
Analyst Recom3.00Target Price40.00
Avg Volume5.67K52W Range2.55 - 5.97
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient's malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
IKT - Inhibikase Therapeutics Inc - Stock Price Chart
TickerIKT [NASD]
CompanyInhibikase Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap8.36MEPS (ttm)-3.62
P/E-EPS this Y51.12%
Forward P/E-EPS next Y32.95%
PEG-EPS past 5Y-23.31%
P/S32.15EPS next 5Y-
P/B0.73EPS Q/Q33.63%
Dividend-Sales Q/Q-100.00%
Insider Own14.50%Inst Own7.16%
Insider Trans0.00%Inst Trans-20.47%
Short Float0.98%EarningsMar 27/a
Analyst Recom1.00Target Price17.50
Avg Volume93.92K52W Range0.79 - 4.35
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in developing protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
THS - Treehouse Foods Inc - Stock Price Chart
TickerTHS [NYSE, RUT]
CompanyTreehouse Foods Inc
CountryUSA
IndustryPackaged Foods
Market Cap1.86BEPS (ttm)0.96
P/E36.07EPS this Y-5.28%
Forward P/E11.88EPS next Y24.43%
PEG2.71EPS past 5Y-
P/S0.53EPS next 5Y13.30%
P/B1.12EPS Q/Q-77.31%
Dividend-Sales Q/Q-8.57%
Insider Own0.81%Inst Own103.03%
Insider Trans-0.91%Inst Trans-9.62%
Short Float4.60%EarningsMay 06/b
Analyst Recom2.56Target Price39.14
Avg Volume554.03K52W Range34.76 - 55.30
TreeHouse Foods, Inc. engages in the manufacture and distribution of private label packaged foods and beverages in North America. Its product portfolio includes snacking, beverages, and meal preparation products, available in shelf stable, refrigerated, frozen, and fresh formats. The company was founded on January 25, 2005 and is headquartered in Oak Brook, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JANA Partners Management, LPDirectorApr 25 '24Option Exercise0.003,26104,910,950Apr 29 04:30 PM
SCALZO JOSEPHDirectorApr 25 '24Option Exercise0.003,26109,233Apr 29 05:05 PM
DeWitt AdamDirectorApr 25 '24Option Exercise0.001,40201,402Apr 29 05:04 PM
Rahman Jill ADirectorApr 25 '24Option Exercise0.003,261014,569Apr 29 05:06 PM
Massman Linda KDirectorApr 25 '24Option Exercise0.003,261026,576Apr 29 05:06 PM
134567891011121316